Tagged: Pfizer

Featured image: New Zealand approves Pfizer vaccine for young people from 12 to 15, but they’ll have to wait their turn

New Zealand approves Pfizer vaccine for young people from 12 to 15, but they’ll have to wait their turn - COVID-19

Guest Author • Jun 25, 2021 •

Michael Plank, University of Canterbury   New Zealand’s medicines regulator Medsafe has granted provisional approval of the Pfizer vaccine for youth aged 12 to 15, and Prime Minister Jacinda Ardern expects cabinet approval to follow next week. Once cabinet approves, 12-15-year-olds will become eligible for vaccination towards the end of the year, after older groups have had their … Read More

Featured image: COVID-19 vaccines prevent spread of the virus too

COVID-19 vaccines prevent spread of the virus too - Code for life

Grant Jacobs • May 13, 2021 •

Many people seem to be reading that our COVID-19 vaccine won’t prevent the spread of COVID-19 from one person to the next.1 If you’re worried about this, this one is for you. We now have evidence the vaccine reduces transmission, and a rough idea of by how much.2 Science is often about pulling different pieces of evidence together, in this … Read More

Featured image: 90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data - COVID-19

Guest Author • Nov 12, 2020 •

Harry Al-Wassiti, Monash University; Colin Pouton, Monash University, and Kylie Quinn, RMIT University German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19. These early results are what is known as an “interim analysis”. It’s an early look at the … Read More